https://www.quantamatrix.com/press_releases/quantamatrix-passes-technical-assessment-accelerating-preparation-for-listing-in-kosdaq/2023-03-16T02:38:59+00:00https://www.quantamatrix.com/press_releases/quantamatrix-passes-preliminary-review-for-kosdaq-listing/2023-03-16T02:38:42+00:00https://www.quantamatrix.com/press_releases/quantamatrix-installs-12-drast-platforms-direct-rapid-antimicrobial-susceptibility-testing-in-ten-european-countries/2023-03-16T02:38:28+00:00https://www.quantamatrix.com/press_releases/quantamatrix-early-diagnosis-kit-for-alzheimers-disease-approved-by-the-ministry-of-food-and-drug-safety/2023-03-16T02:38:08+00:00https://www.quantamatrix.com/press_releases/quantamatrix-applied-for-an-export-license-from-the-korean-ministry-of-food-and-drug-safety-for-the-covid-19-molecular-diagnostic-kit/2023-03-16T02:37:51+00:00https://www.quantamatrix.com/press_releases/quantamatrix-to-debut-on-kosdaq-on-wednesday-12-9-as-ipo-prices-at-23-57-high-end-raising-40-2mn/2023-04-03T21:08:21+00:00https://www.quantamatrix.com/press_releases/limbach-group-adopts-quantamatrix-drasttm-in-routine-clinical-use/2023-03-16T02:36:58+00:00